Delivery Order SPE2DB20D1100-SPE2DB24FC5E8

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $58K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $7,482.20 for the supply of BIKTARVY 50-200-25 MG TABLET medication. The contract was awarded by the Defense Logistics Agency (DLA), a major defense agency, and has an ultimate completion date of September 11, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical program, valued at up to $999,999,999 through December 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The contract, valued at $13,160.61, is a firm fixed-price delivery order with a completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $39,482.98 Firm Fixed Price Delivery Order has an ultimate completion date of April 24, 2024 and was awarded on April 23, 2024. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is an order valued at $5,270.78 for the delivery of BIKTARVY 50-200-25 mg Tablets. The contract was awarded by the Defense Logistics Agency (DLA) and is a Firm Fixed Price Delivery Order with a completion date of July 17, 2024. This order is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, including military...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET medication, with a firm fixed price of $6,840.33 and a completion date of March 8, 2024. The contract does not have any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $13,739.83 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $31,552.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S, with an ultimate completion date of June 26, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award, valued at $2,012.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET. The contract is a delivery order with a firm fixed price and has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,426.78 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET medication, with a completion date of December 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $4,660.98, placed under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award covers the supply of BIKTARVY 50-200-25 MG TABLET in 30-count packages. The contract has an ultimate completion date of November 7, 2024 and was awarded on November 6, 2024. The contract is a firm fixed-price arrangement and does not have a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC5E8
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $57,878.78 for the supply of BIKTARVY 50-200-25 MG TABLET medication. The contract has a completion date of July 2, 2024 and was awarded on July 1, 2024 by the Defense Logistics Agency (DLA), a defense agency.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award is likely a specific order placed against this larger IDC contract. The contract does not have a set-aside designation.

Generated 9/30/24, 4:58 PM